<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>16</volume><submitter>Chen J</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>Shenyuan Yiqi Huoxue Capsule (SYYQ) has clinical evidence to improve coronary microvascular dysfunction (CMD) by tonifying qi and removing blood stasis, but the underlying mechanism remains unclear.&lt;h4>Objective&lt;/h4>This study aims to explore the mechanism by which SYYQ alleviates CMD through a combination of network analysis and both &lt;i>in vivo&lt;/i> and &lt;i>in vitro&lt;/i> experiments.&lt;h4>Methods&lt;/h4>First, network pharmacology was employed to predict the mechanism of SYYQ on CMD. Building upon the findings of network pharmacology, we conducted &lt;i>in vivo&lt;/i> experiment to verify the improvement mechanism of SYYQ in CMD rats using echocardiography, histopathology, serum biochemistry, TUNEL staining, and transmission electron microscopy (TEM). In the context of cell experimen</pubmed_abstract><journal>Frontiers in pharmacology</journal><pagination>1534967</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12358463</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Mechanism of Shenyuan Yiqi Huoxue capsule alleviating coronary microvascular dysfunction: network analysis and experimental evidence.</pubmed_title><pmcid>PMC12358463</pmcid><pubmed_authors>Liu H</pubmed_authors><pubmed_authors>Li X</pubmed_authors><pubmed_authors>Li Y</pubmed_authors><pubmed_authors>Chen J</pubmed_authors><pubmed_authors>Zong H</pubmed_authors><pubmed_authors>Zhang S</pubmed_authors><pubmed_authors>Zhou H</pubmed_authors><pubmed_authors>Shi Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>Mechanism of Shenyuan Yiqi Huoxue capsule alleviating coronary microvascular dysfunction: network analysis and experimental evidence.</name><description>&lt;h4>Background&lt;/h4>Shenyuan Yiqi Huoxue Capsule (SYYQ) has clinical evidence to improve coronary microvascular dysfunction (CMD) by tonifying qi and removing blood stasis, but the underlying mechanism remains unclear.&lt;h4>Objective&lt;/h4>This study aims to explore the mechanism by which SYYQ alleviates CMD through a combination of network analysis and both &lt;i>in vivo&lt;/i> and &lt;i>in vitro&lt;/i> experiments.&lt;h4>Methods&lt;/h4>First, network pharmacology was employed to predict the mechanism of SYYQ on CMD. Building upon the findings of network pharmacology, we conducted &lt;i>in vivo&lt;/i> experiment to verify the improvement mechanism of SYYQ in CMD rats using echocardiography, histopathology, serum biochemistry, TUNEL staining, and transmission electron microscopy (TEM). In the context of cell experimen</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025</publication><modification>2026-05-01T01:42:44.152Z</modification><creation>2026-04-07T16:33:23.322Z</creation></dates><accession>S-EPMC12358463</accession><cross_references><pubmed>40832612</pubmed><doi>10.3389/fphar.2025.1534967</doi></cross_references></HashMap>